In June, two more compounding pharmacies received warning letters from FDA – Sunnymede Pharmacy, doing business as Lee and Company and Lee Pharmacy, and Pharmacy Creations. Both letters include citations involving contamination SOPs and environmental monitoring – the most common problems FDA is finding at sterile compounding facilities (IPQ April 14, 2014).
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]